JP Morgan Maintains Neutral on Healthpeak Properties, Raises Price Target to $21
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Michael Mueller maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $18 to $21.
JP Morgan analyst Michael Mueller maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $18 to $21.